|
|
|
Maine Department of Health & Human Services |
|
Maine Center for Disease Control &
Prevention |
|
(formerly Bureau of Health) |
|
Dora Anne Mills, M.D., M.P.H. |
|
|
|
|
|
|
Pandemic Influenza &
Avian Influenza 101 |
|
Preparedness Efforts |
|
|
|
|
|
|
|
Seasonal influenza |
|
|
|
Avian influenza |
|
Pandemic influenza |
|
|
|
|
|
|
RNA viruses |
|
Genetic engines |
|
A:
Hemagglutinin
Neuraminidase |
|
|
|
|
|
October – April |
|
Influenza Type A |
|
H3N2, H1N1, H1N2 |
|
Influenza Type B |
|
Vaccine |
|
|
|
|
|
|
|
Influenza A |
|
Domestic poultry – can be deadly |
|
High vs. low pathogenic |
|
Wild birds – carriers |
|
Virus in fecal droppings, saliva/nasal discharge |
|
|
|
|
1997
H5N1 Hong Kong |
|
1999
H9N2 Hong Kong |
|
2003
H7N7 Netherlands |
|
2004
H7N3 Canada |
|
2004
H5N1 Southeast Asia |
|
|
|
|
|
|
Global outbreak |
|
Highly contagious |
|
Deadly |
|
|
|
|
|
|
|
1918 Spanish flu (H1N1) |
|
5,000 deaths in Maine |
|
500,00 in U.S. |
|
40,000,000 worldwide |
|
1957 Asian flu (H2N2) |
|
70,000 deaths in U.S. |
|
1-2,000,000 worldwide |
|
1968
Hong Kong flu (H3N2) |
|
34,000 deaths in U.S. |
|
700,000 worldwide |
|
|
|
|
|
|
|
|
Detected in Asia since 1997 |
|
Deadly – 50% mortality in humans |
|
Transmitted birds to mammals and limited human
to human |
|
Evolving quickly |
|
|
|
|
|
217 human cases |
|
In 58 countries |
|
123 deaths |
|
Mortality rate = 57% |
|
|
|
|
|
|
|
|
|
|
|
|
Testing in: |
|
Migratory birds |
|
Poultry industry |
|
|
|
|
Poultry workers |
|
Backyard flock owners |
|
Others – bird lovers, hunters |
|
|
|
|
Food safety |
|
Bird handling |
|
|
|
|
|
|
Detection and Tracking |
|
Care for Isolated and Ill |
|
Vaccines and Antivirals |
|
Food and Other Support |
|
Basic Services and Economic Impact |
|
Communication |
|
Quarantine and Isolation |
|
|
|
|
|
Attack rate of 25%-35% |
|
Duration of up to a year or more in 2 waves |
|
Each wave lasting 6-8 weeks in a community |
|
Healthcare system will be severely taxed if not
overwhelmed |
|
|
|
|
|
|
|
Absenteeism in essential sectors |
|
Health, law enforcement, food |
|
and fuel supplies, education |
|
Economic impact |
|
Psychological stress |
|
|
|
|
Advantages in 2006 |
|
Healthier population |
|
Better medical care |
|
Preparedness |
|
|
|
|
|
|
|
|
|
|
Surveillance |
|
Laboratory Diagnostics |
|
Healthcare Planning |
|
Infection Control |
|
Clinical Guidelines |
|
Vaccine |
|
Antiviral Drugs |
|
Community Disease Control |
|
Travel-Related Risks of Disease |
|
Communications |
|
Workforce Support |
|
|
|
|
Vaccine |
|
Antivirals |
|
Community Disease Control |
|
|
|
|
|
|
Two doses will be required |
|
Vaccine unavailable for 3-6 months |
|
Production will be 3-5 million doses (15 µg)
per week ŕ 10,000 doses per
week in Maine |
|
|
|
|
|
|
Vaccine and
antiviral manufacturers |
|
Health care providers |
|
Those at high risk for severe disease |
|
Public health emergency response workers |
|
Key government leaders |
|
|
|
400,000 in Maine |
|
|
|
|
Virulence |
|
Transmissibility |
|
Drug resistance |
|
Geographic spread |
|
Age-specific attack rates |
|
Morbidity and mortality rates |
|
|
|
|
|
|
|
|
|
Adamantanes |
|
Amantadine |
|
Rimantadine |
|
Neuraminidase inhibitors |
|
Oseltamivir (Tamiflu) |
|
Zanamivir (Relenza) |
|
|
|
|
|
|
Resistance to adamantanes |
|
Neuraminidase inhibitors will be effective in
decreasing morbidity and mortality |
|
Current national stockpile = 5 million courses;
goal is 80 million courses |
|
? Maine stockpile |
|
|
|
|
Patients admitted to hospital |
|
Infected health care workers and EMS providers |
|
Infected high-risk patients |
|
Infected pandemic responders and government
decision-makers |
|
Exposed health care workers |
|
|
|
Equals 40 million courses |
|
(150,000
courses for Maine) |
|
|
|
|
Oseltamivir (Tamiflu) $72.10 |
|
Zanamivir (Relenza) $61.80 |
|
|
|
|
Supply |
|
Effectiveness |
|
Resistance |
|
Equity |
|
Shelf life |
|
|
|
|
|
|
|
|
|
|
Short incubation period of 1-5 days |
|
Infected people are contagious before they have
symptoms |
|
Early symptoms are non-specific, delaying
recognition |
|
|
|
|
|
|
|
To limit or slow spread of pandemic influenza |
|
Social Distancing |
|
|
|
|
|
|
|
Patient isolation |
|
Management of contacts |
|
Contact tracing |
|
Contact monitoring |
|
Quarantine |
|
|
|
|
|
|
Quarantine |
|
Containment measures for specific sites or
buildings |
|
|
|
|
|
|
Promotion of community-wide infection control
measures |
|
Social distancing (snow days) |
|
|
|
|
Role of airborne transmission |
|
Effectiveness of antivirals |
|
Coordination between states and countries |
|
|
|
|
|
|
|
|
|
|
Governor |
|
Incident Commander |
|
MEMA |
|
Coordinator of state’s planning and response to
all emergencies |
|
Maine CDC |
|
Develops public health emergency response plans |
|
Strategy lead in state’s response to Pandemic
Influenza |
|
Sits with Governor during public health
emergencies |
|
Maine Department of Agriculture |
|
Develops response plans for zoonoses |
|
Strategy lead in state’s response to Avian
Influenza |
|
Sits with Governor during animal health
emergencies |
|
|
|
|
|
|
1997 – 2001 |
|
Two statewide Pan Flu Conferences |
|
Statewide Plan |
|
Two exercises |
|
2001 – 2005 |
|
Post 9/11 Federal Funds |
|
Early Detection System |
|
Communication Systems |
|
Response System |
|
December, 2005 Pan Flu Conference |
|
|
|
|
|
|
3-part process: |
|
Update Maine’s Pandemic Influenza Plan |
|
Development of sub-state Pandemic Influenza
plans |
|
County plans |
|
Hospital plans |
|
Exercise and drills of the plans |
|
|
|
|
|
|
Early detection |
|
Response systems |
|
Communications |
|
Training |
|
Exercises and drills |
|
|
|
|
|
|
|
|
|
|
|
|
Need to: |
|
Keep
focused on the known |
|
Be
creative |
|
Don’t
wait for someone else |
|
|
|
|
|
|
|